Email

Search

Media

TKT Archive


In July 2005 Shire announced that the acquisition of Transkaryotic Therapies Inc. (TKT) has successfully closed.


spacer gif
 
14 Jul 2005
TKT Confirms That Board of Directors Unanimously Recommends That Stockholders Approve Shire Transaction
spacer gif
 
12 Jul 2005
TKT Issues Open Letter to Stockholders
spacer gif
 
27 Jun 2005
TKT to Hold Special Meeting of Stockholders on July 27, 2005
spacer gif
 
20 Jun 2005
TKT Reports Positive Top-Line Results of Hunter Syndrome Pivotal Trial
spacer gif
 
13 Jun 2005
TKT Announces Expiration of Both Hart-Scott-Rodino Waiting Period and SEC Review Period of Preliminary Proxy Statement
spacer gif
 
14 May 2005
TKT Receives Formal Order of Investigation by SEC
spacer gif
 
27 Apr 2005
TKT to Report First Quarter 2005 Financial Results on May 5, 2005
spacer gif
 
27 Apr 2005
TKT Assessing Impact of Fire at Manufacturing Facility
spacer gif
 
21 Apr 2005
TKT Announces Agreement to be Acquired by Shire for $1.6 Billion
spacer gif
 
20 Apr 2005
TKT Achieves GA-GCB Clinical Milestone
spacer gif
 
29 Mar 2005
TKT Announces Appointment of Eric Pauwels as Senior Vice President, Global Commercial Operations
spacer gif
 
28 Mar 2005
New Website Offers Comprehensive Information on Hunter Syndrome
spacer gif
 
24 Mar 2005
TKT to Present at Two Upcoming Healthcare Conferences
spacer gif
 
09 Mar 2005
TKT to Present at SG Cowen Securities' 25th Annual Healthcare Conference
spacer gif
 
24 Feb 2005
National MPS Society and Transkaryotic Therapies, Inc. [TKTX] to Ring The NASDAQ Stock Market Opening Bell
spacer gif
 
15 Feb 2005
Tamara L. Joseph Named General Counsel of TKT
spacer gif
 
10 Feb 2005
TKT to Report Fourth Quarter and Year-End 2004 Financial Results on February 23, 2005
spacer gif
 
04 Feb 2005
TKT Appoints Theresa Heggie as General Manager, Europe
spacer gif
 
24 Jan 2005
Genzyme Sues to Halt TKT Gaucher Trial
spacer gif
 
11 Jan 2005
TKT Provides Update on Product Pipeline at JPMorgan Healthcare Conference
spacer gif
 
04 Jan 2005
TKT to Present at JPMorgan's Annual HealthCare Conference